Statement of Organization, Functions, and Delegations of Authority, 13807-13810 [2016-05714]
Download as PDF
13807
Federal Register / Vol. 81, No. 50 / Tuesday, March 15, 2016 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
45
45
45
45
45
CFR
CFR
CFR
CFR
CFR
164.306
164.308
164.308
164.310
164.314
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Response type
Total burden
hours
Justification ..........................................................................
Security incident report ........................................................
Contingency plan .................................................................
Physical safeguard policies and procedures .......................
Problem reports ...................................................................
75,000
50
60,000
500
10
3
1
1
1
1
15/60
8
8
10/60
1
56,250
400
480,000
83
10
Total ..........................................................................................................
........................
........................
........................
536,743
OS specifically requests comments on
(1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Darius Taylor,
Information Collection Clearance Officer.
[FR Doc. 2016–05806 Filed 3–14–16; 8:45 am]
BILLING CODE 4153–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Inspector General
[OIG–1206–N]
Statement of Organization, Functions,
and Delegations of Authority
Office of Inspector General
(OIG), HHS.
ACTION: Notice.
AGENCY:
This notice replaces all
language in Part A (Office of the
Secretary) of the Statement of
Organization, Functions, and
Delegations of Authority for the
Department of Health and Human
Services (HHS), Office of Inspector
General (OIG) (70 FR 20147, as amended
April 18, 2005; as last amended at 73 FR
7568, dated February 8, 2008).
The statement of organization,
functions, and delegations of authority
conforms to and carries out the statutory
requirements for operating OIG. The
organizational changes reflected in this
notice are primarily to realign the
functions within OIG to better reflect
the current work environment and
priorities, and to more clearly delineate
responsibilities for the various activities
within OIG’s offices. In addition, this
notice removes all of Chapter A and
establishes Chapter Q.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:40 Mar 14, 2016
Jkt 238001
OIG was established by law as an
independent and objective oversight
unit of the Department to carry out the
mission of preventing fraud and abuse
and promoting economy, efficiency and
effectiveness of HHS programs and
operations. In furtherance of this
mission, the organization:
A. Conducts and supervises audits,
investigations, evaluations and
inspections relating to HHS programs
and operations.
B. Identifies systemic weaknesses
giving rise to opportunities for fraud
and abuse in HHS programs and
operations and makes recommendations
to prevent their recurrence.
C. Leads and coordinates activities to
prevent and detect fraud and abuse in
HHS programs and operations.
D. Detects wrongdoers and abusers of
HHS programs and beneficiaries so
appropriate remedies may be brought to
bear, including imposing administrative
sanctions against providers of health
care under Medicare and Medicaid who
commit certain prohibited acts.
E. Keeps the Secretary and Congress
fully and currently informed about
problems and deficiencies in the
administration of HHS programs and
operations and about the need for and
progress of corrective action.
In addition, OIG works with the
Department of Justice (DOJ), on behalf of
the Secretary, to operate the Health Care
Fraud and Abuse Control Program. In
accordance with authority enacted in its
annual appropriations, OIG also
provides protection services to the
Secretary and conducts criminal
investigations of violations of Federal
child support provisions.
In support of its mission, OIG carries
out and maintains an internal quality
assurance system and a peer review
system with other Offices of Inspectors
General, including periodic quality
assessment studies and quality control
reviews, to provide reasonable
assurance that applicable laws,
regulations, policies, procedures,
standards, and other requirements are
followed, are effective, and are
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
functioning as intended in OIG
operations.
Section Q, Office of Inspector General—
Organization
There is at the head of OIG a statutory
Inspector General, appointed by the
President and confirmed by the Senate.
This office consists of six organizational
units:
A. Immediate Office of the Inspector
General (QA)
B. Office of Management and Policy
(QC)
C. Office of Evaluation and Inspections
(QE)
D. Office of Counsel to the Inspector
General (QG)
E. Office of Audit Services (QH)
F. Office of Investigations (QJ)
Section Q, Office of Inspector General—
Functions
The component sections that follow
describe the specific functions of the
organization.
Section Q.00, Immediate Office of the
Inspector General—Mission
The Immediate Office of the Inspector
General is directly responsible for
meeting the statutory mission of OIG as
a whole and for promoting effective OIG
internal quality assurance systems,
including quality assessment studies
and quality control reviews of OIG
processes and products. The office also
plans, conducts and participates in a
variety of interagency cooperative
projects and undertakings relating to
fraud and abuse with the DOJ, the
Centers for Medicare & Medicaid
Services (CMS) and other governmental
agencies, and is responsible for the
reporting and legislative and regulatory
review functions required by the
Inspector General Act.
Section QA.10, Immediate Office of the
Inspector General—Organization
The Immediate Office is comprised of
the Inspector General, the Principal
Deputy Inspector General, Chief of Staff,
E:\FR\FM\15MRN1.SGM
15MRN1
13808
Federal Register / Vol. 81, No. 50 / Tuesday, March 15, 2016 / Notices
several technical advisors, including the
Chief Medical Officer, and staff.
Section QA.20, Immediate Office of the
Inspector General—Functions
The Inspector General is appointed by
the President, with the advice and
consent of the Senate, and reports to
and is under the general supervision of
the Secretary or, to the extent such
authority is delegated, the Deputy
Secretary, but does not report to and is
not subject to supervision by any other
officer in the Department. In keeping
with the independence conferred by the
Inspector General Act, the Inspector
General assumes and exercises, through
line management, all functional
authorities related to the administration
and management of OIG and all
mission-related authorities stated or
implied in the law or delegated directly
from the Secretary.
The Inspector General provides
executive leadership to the organization
and exercises general supervision over
the personnel and functions of its major
components. The Inspector General
determines the budget needs of OIG,
sets OIG policies and priorities, oversees
OIG operations and provides reports to
the Secretary and Congress. By statute,
the Inspector General exercises general
personnel authority, e.g., selection,
promotion, and assignment of
employees, including members of the
Senior Executive Service. The Inspector
General delegates related authorities as
appropriate. The Principal Deputy
Inspector General assists the Inspector
General in the management of OIG, and
during the absence of the Inspector
General, acts as the Inspector General.
The Principal Deputy Inspector General
supervises the Chief Counsel to the
Inspector General, the Deputy
Inspectors General, who head the major
OIG components, as well as the Chief of
Staff.
Section QC.00, Office of Management
and Policy—Mission
The Office of Management and Policy
(OMP) provides management, guidance,
and resources in support of OIG.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Section QC.10, Office of Management
and Policy—Organization
The office is directed by the Deputy
Inspector General for Management and
Policy, who, aided by Assistant
Inspectors General, assures that OIG has
the financial and administrative
resources necessary to fulfill its mission.
This office carries out its
responsibilities through headquarters
functions.
VerDate Sep<11>2014
17:40 Mar 14, 2016
Jkt 238001
Section QC.20, Office of Management
and Policy—Functions
The staffs within OMP are responsible
for formulating and executing the
budget, developing policy, managing
information technology, human
resources, executive resources, OIG
procurement activities and OIG physical
space. OMP also executes and maintains
an internal quality assurance system,
which includes quality control reviews
of OMP processes and products to
ensure that OIG policies and procedures
are followed and function as intended.
Additionally, the office leads OIG’s
congressional and regulatory functions;
media and public communications;
coordinates strategic planning and
mandated Inspector General reporting,
including Work Plans and Semi-Annual
Reports to Congress; and responds to all
requests made under the Freedom of
Information Act.
Finally, the office leads and
coordinates OIG’s data analysis
management and organizational
performance management activities.
Section QE.00, Office of Evaluation and
Inspections—Mission
The Office of Evaluation and
Inspections (OEI) is responsible for
conducting in-depth evaluations of HHS
programs, operations, and processes to
identify vulnerabilities and recommend
corrective action; to prevent and detect
fraud and abuse; and to promote
efficiency and effectiveness in HHS
programs and operations. OEI conducts
its work in accordance with the Quality
Standards for Inspection and Evaluation
issued by the Council of the Inspectors
General on Integrity and Efficiency.
Section QE.10, Office of Evaluation and
Inspections—Organization
This office is directed by the Deputy
Inspector General for OEI who, aided by
Assistant Inspectors General, is
responsible for carrying out OIG’s
responsibilities to evaluate the
effectiveness and efficiency of HHS
programs and operations. The office is
comprised of headquarters and regional
functions.
Section QE.20, Office of Evaluation and
Inspections—Functions
OEI is responsible for conducting
evaluations of HHS programs;
conducting data and trend analysis; and
recommending changes in programs,
procedures, policies, regulations, and
legislation. The Office develops
evaluation policies, procedures,
techniques and guidelines to be
followed by all OEI staff in conducting
evaluations. The office maintains an
internal quality assurance program. OEI
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
also oversees the activities of State
Medicaid Fraud Control Units (MFCUs)
to ensure the MFCUs’ compliance with
Federal grant regulations, administrative
rules, and performance standards for the
purpose of certifying or recertifying the
MFCUs annually.
The office also maintains automated
data and management information
systems used by all OEI employees, a
quality assurance/peer review program
and policy and procedure manuals.
Section QG.00, Office of Counsel to the
Inspector General—Mission
In accordance with section 3(g) of the
Inspector General Act (5 U.S.C. App.
§ 3(g)), the Office of Counsel to the
Inspector General (OCIG) provides all
legal advice to OIG and represents OIG
in administrative litigation. OCIG
proposes and litigates civil money
penalty (CMP) and program exclusion
cases within the jurisdiction of OIG. It
coordinates False Claims Act matters
involving HHS programs and resolves
voluntary disclosure cases. OCIG
develops guidance to assist providers in
establishing compliance programs;
monitors ongoing compliance of
providers subject to integrity
agreements; and promotes industry
awareness through advisory opinions,
fraud alerts, and special advisory
bulletins.
Section QG.10, Office of Counsel to the
Inspector General—Organization
The office is directed by the Chief
Counsel to the Inspector General and
aided by Assistant Inspectors General.
The office carries out its responsibilities
through headquarters functions.
Section QG.20, Office of Counsel to the
Inspector General—Functions
The office provides legal advice to
OIG on issues that arise in the exercise
of OIG’s responsibilities under the
Inspector General Act of 1978. Such
issues include the scope and exercise of
the Inspector General’s authorities and
responsibilities; investigative
techniques and procedures (including
criminal procedure); the sufficiency and
impact of legislative proposals affecting
OIG and HHS; and the conduct and
resolution of investigations, audits and
inspections. The office evaluates the
legal sufficiency of OIG findings and
recommendations and develops formal
legal opinions to support these findings
and recommendations. The office
provides legal advice on OIG internal
administration and operations,
including appropriations, delegations of
authority, OIG regulations, personnel
matters, the disclosure of information
under the Freedom of Information Act,
E:\FR\FM\15MRN1.SGM
15MRN1
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 50 / Tuesday, March 15, 2016 / Notices
and the safeguarding of information
under the Privacy Act and serves as
OIG’s Deputy Ethics Officer. The office
is responsible for the clearance and
enforcement of subpoenas issued by
OIG.
The office represents OIG in
administrative litigation and related
appeals. This includes representing OIG
in personnel and Equal Employment
Opportunity matters; and coordinating
OIG’s representation in Federal tort
actions involving OIG employees.
The office also determines whether to
propose or implement administrative
sanctions, including CMPs and
assessments within the jurisdiction of
OIG. The office litigates and resolves all
appealed or contested exclusions from
participation in Federal health care
programs under the Social Security Act.
In coordination with DOJ, the office
represents HHS in all False Claims Act
cases, including qui tam cases, and is
responsible for final approval of civil
False Claims Act settlements for the
Department, including the resolution of
the program exclusion authorities that
have been delegated to OIG.
The office, in conjunction with the
Office of Investigations, coordinates
resolution of all voluntary and
mandatory disclosure under the OIG
Provider Self-Disclosure Protocol, the
contractor self-disclosure requirement
and otherwise. The office develops and
monitors corporate and individual
integrity agreements adopted in
connection with settlement agreements,
conducts on-site reviews, and develops
audit and investigative review standards
for monitoring such integrity
agreements in cooperation with other
OIG components. The office resolves
breaches of integrity agreements through
the development of corrective action
plans and through the imposition of
sanctions.
Finally, the office issues advisory
opinions to the health care industry and
members of the public on whether a
current or proposed activity would
constitute grounds for the imposition of
a sanction under the anti-kickback
statute, the CMP law or the program
exclusion authorities. The office
develops procedures for submitting and
processing requests for advisory
opinions and for determining the fees
that will be imposed. The office solicits
and responds to proposals for new
regulatory safe harbors to the antikickback statute, modifications to
existing safe harbors, and new fraud
alerts. The office consults with DOJ on
proposed advisory opinions and safe
harbors before issuance or publication.
The office provides legal advice to the
components of OIG, other HHS offices
VerDate Sep<11>2014
17:40 Mar 14, 2016
Jkt 238001
and DOJ concerning matters involving
the interpretation of the anti-kickback
statute and other legal authorities, and
assists those components or offices in
analyzing the applicability of the antikickback statute to particular practices
or activities under review.
Section QH.00, Office of Audit
Services—Mission
The Office of Audit Services (OAS) is
responsible for protecting the integrity
of HHS operations and programs by
conducting audits that identify and
report ways to improve the economy,
efficiency, and effectiveness of
operations and services to beneficiaries
of HHS programs, and help reduce
fraud, waste, abuse, and
mismanagement. OAS conducts audits
and oversees audit work performed by
others. It conducts its work in
accordance with Government Auditing
Standards and follows applicable legal,
regulatory, and administrative
requirements.
Section QH.10, Office of Audit
Services—Organization
The office is directed by the Deputy
Inspector General for Audit Services
who, aided by Assistant Inspectors
General, performs the functions
designated in Section 3(d)(1)A of the
Inspector General Act) for the position
of Assistant Inspector General for
Auditing. The office is comprised of
headquarters and regional functions and
also includes a designated
Whistleblower Protection Ombudsman,
and the functions thereof, as required by
law (section 3(d)(1)C of the Inspector
General Act).
Section QH.20, Office of Audit
Services—Functions
OAS establishes audit priorities;
performs audits; oversees the progress of
audits; coordinates on bodies of work
with stakeholders; recommends changes
in program policies, regulations, and
legislation to prevent fraud, waste, and
abuse and improve programs and
operations; and reports on the impact of
audit work. The office develops audit
policies, procedures, techniques, and
guidelines to be followed by all OAS
staff in conducting audits. OAS
maintains an internal quality assurance
program, conducts peer reviews of other
OIGs and maintains automated data and
management information systems used
by all OAS employees. The office also
provides oversight for audits of state
and local governments, universities, and
nonprofit organizations conducted by
non-Federal auditors. The office
provides education to agency employees
about prohibitions on retaliation, and
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
13809
the rights and remedies against
retaliation, for protected disclosures, as
required of the Whistleblower
Protection Ombudsman.
Section QJ.00, Office of Investigations—
Mission
The Office of Investigations (OI) is
granted full statutory law enforcement
authority under the Homeland Security
Act of 2003 (Pub. L. 107–296). OI is
responsible for protecting the integrity
of the programs administered and/or
funded by HHS by conducting criminal,
civil and administrative investigations
of fraud and misconduct related to HHS
programs, operations and employees.
The office serves as OIG’s liaison to the
DOJ on all matters relating to
investigations of HHS programs and
personnel, and reports to the Attorney
General when there are reasonable
grounds to believe Federal criminal law
has been violated. OI serves as a liaison
to the CMS, State licensing boards, and
other outside organizations and entities
with regard to exclusion, compliance,
and enforcement activities.
Section QJ.10, Office of Investigations—
Organization
The office is directed by the Deputy
Inspector General for Investigations,
aided by Assistant Inspectors General,
and performs the functions designated
in the law (section 3(d)(1)B of the
Inspector General Act) for the position
of Assistant Inspector General for
Investigations. The office is comprised
of headquarters and regional functions.
Section QJ.20, Office of Investigations—
Functions
OI conducts criminal, civil, and
administrative investigations of
allegations of fraud, waste, abuse,
mismanagement, and violations of
standards of conduct within the
jurisdiction of OIG. OI establishes
investigative priorities, evaluates the
progress of investigations, and reports
findings to the Inspector General. The
office develops and implements
investigative techniques, programs,
guidelines, and policies; manages OI’s
quality assurance/peer review program
and conducts peer reviews of other
OIGs. OI also carries out and maintains
an internal quality assurance system.
The system includes quality assessment
studies and quality control reviews of
OI processes and products to ensure that
policies and procedures are followed
effectively, and are functioning as
intended. The office effectuates
mandatory and permissive exclusions
from participation in Federal health care
programs under the Social Security Act;
decides on all requests for reinstatement
E:\FR\FM\15MRN1.SGM
15MRN1
13810
Federal Register / Vol. 81, No. 50 / Tuesday, March 15, 2016 / Notices
from, or waiver of, exclusions; and
participates in developing standards
governing the imposition of these
exclusion authorities. The office also
oversees OIG’s suspension and
debarment referral program. OI
implements policies and procedures
and plans, develops, implements and
evaluates all levels of training for OI
employees. The staff provides for the
personal protection of the Secretary and
other Department officials, as needed,
and all emergency operations
preparedness and response. OI
coordinates the adoption of advanced
digital forensic acquisition and
examination and information security
technologies to assist in the
investigation, prevention and detection
of fraud and abuse; maintains an
automated data and management
information system used by all OI
employees; provides technical expertise
on computer applications for
investigations; and coordinates and
approves investigative computer
matches with other agencies.
In addition, the office operates a tollfree hotline to permit individuals to
report suspected fraud, waste and abuse
within HHS programs.
Dated: March 9, 2016.
Daniel R. Levinson,
Inspector General.
[FR Doc. 2016–05714 Filed 3–14–16; 8:45 am]
BILLING CODE 4152–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Cell Biology
Topics.
Date: March 31, 2016.
Time: 1:00 p.m. to 5:00 p.m.
VerDate Sep<11>2014
17:40 Mar 14, 2016
Jkt 238001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Elena Smirnova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187,
MSC 7840, Bethesda, MD 20892, 301–435–
1236, smirnove@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR Panel:
Translational Research in Pediatric and
Obstetric Pharmacology and Therapeutics.
Date: April 6, 2016.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, EMNR IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6182
MSC 7892, Bethesda, MD 20892, 301– 435–
2514, riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Child Psychopathology, Emotion,
Learning and Memory.
Date: April 6, 2016.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848, Bethesda,
MD 20892, (301) 402–4411, tianbi@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Endocrinology and Reproduction.
Date: April 6, 2016.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael Knecht, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892, (301) 435–
1046, knechtm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Urologic
and Urogynecologic Small Business
Applications.
Date: April 7–8, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR15–360
Mycobacterial Induced Immunity in HIVInfected and Uninfected Individuals.
Date: April 7, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
Bethesda, MD 20892, 301–451–8754, tuoj@
nei.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Biological Chemistry and
Macromolecular Biophysics.
Date: April 7, 2016.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael Eissenstat, Ph.D.,
Scientific Review Officer, BCMB IRG, Center
for Scientific Review,National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
Bethesda, MD 20892, 301–435–1722,
eissenstatma@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Virology.
Date: April 7, 2016.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Marci Scidmore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–435–
1149, marci.scidmore@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Infectious Diseases and Microbiology.
Date: April 7, 2016.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Neerja Kaushik-Basu,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301) 435–
2306, kaushikbasun@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\15MRN1.SGM
15MRN1
Agencies
[Federal Register Volume 81, Number 50 (Tuesday, March 15, 2016)]
[Notices]
[Pages 13807-13810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05714]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of Inspector General
[OIG-1206-N]
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Office of Inspector General (OIG), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice replaces all language in Part A (Office of the
Secretary) of the Statement of Organization, Functions, and Delegations
of Authority for the Department of Health and Human Services (HHS),
Office of Inspector General (OIG) (70 FR 20147, as amended April 18,
2005; as last amended at 73 FR 7568, dated February 8, 2008).
The statement of organization, functions, and delegations of
authority conforms to and carries out the statutory requirements for
operating OIG. The organizational changes reflected in this notice are
primarily to realign the functions within OIG to better reflect the
current work environment and priorities, and to more clearly delineate
responsibilities for the various activities within OIG's offices. In
addition, this notice removes all of Chapter A and establishes Chapter
Q.
OIG was established by law as an independent and objective
oversight unit of the Department to carry out the mission of preventing
fraud and abuse and promoting economy, efficiency and effectiveness of
HHS programs and operations. In furtherance of this mission, the
organization:
A. Conducts and supervises audits, investigations, evaluations and
inspections relating to HHS programs and operations.
B. Identifies systemic weaknesses giving rise to opportunities for
fraud and abuse in HHS programs and operations and makes
recommendations to prevent their recurrence.
C. Leads and coordinates activities to prevent and detect fraud and
abuse in HHS programs and operations.
D. Detects wrongdoers and abusers of HHS programs and beneficiaries
so appropriate remedies may be brought to bear, including imposing
administrative sanctions against providers of health care under
Medicare and Medicaid who commit certain prohibited acts.
E. Keeps the Secretary and Congress fully and currently informed
about problems and deficiencies in the administration of HHS programs
and operations and about the need for and progress of corrective
action.
In addition, OIG works with the Department of Justice (DOJ), on
behalf of the Secretary, to operate the Health Care Fraud and Abuse
Control Program. In accordance with authority enacted in its annual
appropriations, OIG also provides protection services to the Secretary
and conducts criminal investigations of violations of Federal child
support provisions.
In support of its mission, OIG carries out and maintains an
internal quality assurance system and a peer review system with other
Offices of Inspectors General, including periodic quality assessment
studies and quality control reviews, to provide reasonable assurance
that applicable laws, regulations, policies, procedures, standards, and
other requirements are followed, are effective, and are functioning as
intended in OIG operations.
Section Q, Office of Inspector General--Organization
There is at the head of OIG a statutory Inspector General,
appointed by the President and confirmed by the Senate. This office
consists of six organizational units:
A. Immediate Office of the Inspector General (QA)
B. Office of Management and Policy (QC)
C. Office of Evaluation and Inspections (QE)
D. Office of Counsel to the Inspector General (QG)
E. Office of Audit Services (QH)
F. Office of Investigations (QJ)
Section Q, Office of Inspector General--Functions
The component sections that follow describe the specific functions
of the organization.
Section Q.00, Immediate Office of the Inspector General--Mission
The Immediate Office of the Inspector General is directly
responsible for meeting the statutory mission of OIG as a whole and for
promoting effective OIG internal quality assurance systems, including
quality assessment studies and quality control reviews of OIG processes
and products. The office also plans, conducts and participates in a
variety of interagency cooperative projects and undertakings relating
to fraud and abuse with the DOJ, the Centers for Medicare & Medicaid
Services (CMS) and other governmental agencies, and is responsible for
the reporting and legislative and regulatory review functions required
by the Inspector General Act.
Section QA.10, Immediate Office of the Inspector General--Organization
The Immediate Office is comprised of the Inspector General, the
Principal Deputy Inspector General, Chief of Staff,
[[Page 13808]]
several technical advisors, including the Chief Medical Officer, and
staff.
Section QA.20, Immediate Office of the Inspector General--Functions
The Inspector General is appointed by the President, with the
advice and consent of the Senate, and reports to and is under the
general supervision of the Secretary or, to the extent such authority
is delegated, the Deputy Secretary, but does not report to and is not
subject to supervision by any other officer in the Department. In
keeping with the independence conferred by the Inspector General Act,
the Inspector General assumes and exercises, through line management,
all functional authorities related to the administration and management
of OIG and all mission-related authorities stated or implied in the law
or delegated directly from the Secretary.
The Inspector General provides executive leadership to the
organization and exercises general supervision over the personnel and
functions of its major components. The Inspector General determines the
budget needs of OIG, sets OIG policies and priorities, oversees OIG
operations and provides reports to the Secretary and Congress. By
statute, the Inspector General exercises general personnel authority,
e.g., selection, promotion, and assignment of employees, including
members of the Senior Executive Service. The Inspector General
delegates related authorities as appropriate. The Principal Deputy
Inspector General assists the Inspector General in the management of
OIG, and during the absence of the Inspector General, acts as the
Inspector General. The Principal Deputy Inspector General supervises
the Chief Counsel to the Inspector General, the Deputy Inspectors
General, who head the major OIG components, as well as the Chief of
Staff.
Section QC.00, Office of Management and Policy--Mission
The Office of Management and Policy (OMP) provides management,
guidance, and resources in support of OIG.
Section QC.10, Office of Management and Policy--Organization
The office is directed by the Deputy Inspector General for
Management and Policy, who, aided by Assistant Inspectors General,
assures that OIG has the financial and administrative resources
necessary to fulfill its mission. This office carries out its
responsibilities through headquarters functions.
Section QC.20, Office of Management and Policy--Functions
The staffs within OMP are responsible for formulating and executing
the budget, developing policy, managing information technology, human
resources, executive resources, OIG procurement activities and OIG
physical space. OMP also executes and maintains an internal quality
assurance system, which includes quality control reviews of OMP
processes and products to ensure that OIG policies and procedures are
followed and function as intended. Additionally, the office leads OIG's
congressional and regulatory functions; media and public
communications; coordinates strategic planning and mandated Inspector
General reporting, including Work Plans and Semi-Annual Reports to
Congress; and responds to all requests made under the Freedom of
Information Act.
Finally, the office leads and coordinates OIG's data analysis
management and organizational performance management activities.
Section QE.00, Office of Evaluation and Inspections--Mission
The Office of Evaluation and Inspections (OEI) is responsible for
conducting in-depth evaluations of HHS programs, operations, and
processes to identify vulnerabilities and recommend corrective action;
to prevent and detect fraud and abuse; and to promote efficiency and
effectiveness in HHS programs and operations. OEI conducts its work in
accordance with the Quality Standards for Inspection and Evaluation
issued by the Council of the Inspectors General on Integrity and
Efficiency.
Section QE.10, Office of Evaluation and Inspections--Organization
This office is directed by the Deputy Inspector General for OEI
who, aided by Assistant Inspectors General, is responsible for carrying
out OIG's responsibilities to evaluate the effectiveness and efficiency
of HHS programs and operations. The office is comprised of headquarters
and regional functions.
Section QE.20, Office of Evaluation and Inspections--Functions
OEI is responsible for conducting evaluations of HHS programs;
conducting data and trend analysis; and recommending changes in
programs, procedures, policies, regulations, and legislation. The
Office develops evaluation policies, procedures, techniques and
guidelines to be followed by all OEI staff in conducting evaluations.
The office maintains an internal quality assurance program. OEI also
oversees the activities of State Medicaid Fraud Control Units (MFCUs)
to ensure the MFCUs' compliance with Federal grant regulations,
administrative rules, and performance standards for the purpose of
certifying or recertifying the MFCUs annually.
The office also maintains automated data and management information
systems used by all OEI employees, a quality assurance/peer review
program and policy and procedure manuals.
Section QG.00, Office of Counsel to the Inspector General--Mission
In accordance with section 3(g) of the Inspector General Act (5
U.S.C. App. Sec. 3(g)), the Office of Counsel to the Inspector General
(OCIG) provides all legal advice to OIG and represents OIG in
administrative litigation. OCIG proposes and litigates civil money
penalty (CMP) and program exclusion cases within the jurisdiction of
OIG. It coordinates False Claims Act matters involving HHS programs and
resolves voluntary disclosure cases. OCIG develops guidance to assist
providers in establishing compliance programs; monitors ongoing
compliance of providers subject to integrity agreements; and promotes
industry awareness through advisory opinions, fraud alerts, and special
advisory bulletins.
Section QG.10, Office of Counsel to the Inspector General--Organization
The office is directed by the Chief Counsel to the Inspector
General and aided by Assistant Inspectors General. The office carries
out its responsibilities through headquarters functions.
Section QG.20, Office of Counsel to the Inspector General--Functions
The office provides legal advice to OIG on issues that arise in the
exercise of OIG's responsibilities under the Inspector General Act of
1978. Such issues include the scope and exercise of the Inspector
General's authorities and responsibilities; investigative techniques
and procedures (including criminal procedure); the sufficiency and
impact of legislative proposals affecting OIG and HHS; and the conduct
and resolution of investigations, audits and inspections. The office
evaluates the legal sufficiency of OIG findings and recommendations and
develops formal legal opinions to support these findings and
recommendations. The office provides legal advice on OIG internal
administration and operations, including appropriations, delegations of
authority, OIG regulations, personnel matters, the disclosure of
information under the Freedom of Information Act,
[[Page 13809]]
and the safeguarding of information under the Privacy Act and serves as
OIG's Deputy Ethics Officer. The office is responsible for the
clearance and enforcement of subpoenas issued by OIG.
The office represents OIG in administrative litigation and related
appeals. This includes representing OIG in personnel and Equal
Employment Opportunity matters; and coordinating OIG's representation
in Federal tort actions involving OIG employees.
The office also determines whether to propose or implement
administrative sanctions, including CMPs and assessments within the
jurisdiction of OIG. The office litigates and resolves all appealed or
contested exclusions from participation in Federal health care programs
under the Social Security Act. In coordination with DOJ, the office
represents HHS in all False Claims Act cases, including qui tam cases,
and is responsible for final approval of civil False Claims Act
settlements for the Department, including the resolution of the program
exclusion authorities that have been delegated to OIG.
The office, in conjunction with the Office of Investigations,
coordinates resolution of all voluntary and mandatory disclosure under
the OIG Provider Self-Disclosure Protocol, the contractor self-
disclosure requirement and otherwise. The office develops and monitors
corporate and individual integrity agreements adopted in connection
with settlement agreements, conducts on-site reviews, and develops
audit and investigative review standards for monitoring such integrity
agreements in cooperation with other OIG components. The office
resolves breaches of integrity agreements through the development of
corrective action plans and through the imposition of sanctions.
Finally, the office issues advisory opinions to the health care
industry and members of the public on whether a current or proposed
activity would constitute grounds for the imposition of a sanction
under the anti-kickback statute, the CMP law or the program exclusion
authorities. The office develops procedures for submitting and
processing requests for advisory opinions and for determining the fees
that will be imposed. The office solicits and responds to proposals for
new regulatory safe harbors to the anti-kickback statute, modifications
to existing safe harbors, and new fraud alerts. The office consults
with DOJ on proposed advisory opinions and safe harbors before issuance
or publication. The office provides legal advice to the components of
OIG, other HHS offices and DOJ concerning matters involving the
interpretation of the anti-kickback statute and other legal
authorities, and assists those components or offices in analyzing the
applicability of the anti-kickback statute to particular practices or
activities under review.
Section QH.00, Office of Audit Services--Mission
The Office of Audit Services (OAS) is responsible for protecting
the integrity of HHS operations and programs by conducting audits that
identify and report ways to improve the economy, efficiency, and
effectiveness of operations and services to beneficiaries of HHS
programs, and help reduce fraud, waste, abuse, and mismanagement. OAS
conducts audits and oversees audit work performed by others. It
conducts its work in accordance with Government Auditing Standards and
follows applicable legal, regulatory, and administrative requirements.
Section QH.10, Office of Audit Services--Organization
The office is directed by the Deputy Inspector General for Audit
Services who, aided by Assistant Inspectors General, performs the
functions designated in Section 3(d)(1)A of the Inspector General Act)
for the position of Assistant Inspector General for Auditing. The
office is comprised of headquarters and regional functions and also
includes a designated Whistleblower Protection Ombudsman, and the
functions thereof, as required by law (section 3(d)(1)C of the
Inspector General Act).
Section QH.20, Office of Audit Services--Functions
OAS establishes audit priorities; performs audits; oversees the
progress of audits; coordinates on bodies of work with stakeholders;
recommends changes in program policies, regulations, and legislation to
prevent fraud, waste, and abuse and improve programs and operations;
and reports on the impact of audit work. The office develops audit
policies, procedures, techniques, and guidelines to be followed by all
OAS staff in conducting audits. OAS maintains an internal quality
assurance program, conducts peer reviews of other OIGs and maintains
automated data and management information systems used by all OAS
employees. The office also provides oversight for audits of state and
local governments, universities, and nonprofit organizations conducted
by non-Federal auditors. The office provides education to agency
employees about prohibitions on retaliation, and the rights and
remedies against retaliation, for protected disclosures, as required of
the Whistleblower Protection Ombudsman.
Section QJ.00, Office of Investigations--Mission
The Office of Investigations (OI) is granted full statutory law
enforcement authority under the Homeland Security Act of 2003 (Pub. L.
107-296). OI is responsible for protecting the integrity of the
programs administered and/or funded by HHS by conducting criminal,
civil and administrative investigations of fraud and misconduct related
to HHS programs, operations and employees. The office serves as OIG's
liaison to the DOJ on all matters relating to investigations of HHS
programs and personnel, and reports to the Attorney General when there
are reasonable grounds to believe Federal criminal law has been
violated. OI serves as a liaison to the CMS, State licensing boards,
and other outside organizations and entities with regard to exclusion,
compliance, and enforcement activities.
Section QJ.10, Office of Investigations--Organization
The office is directed by the Deputy Inspector General for
Investigations, aided by Assistant Inspectors General, and performs the
functions designated in the law (section 3(d)(1)B of the Inspector
General Act) for the position of Assistant Inspector General for
Investigations. The office is comprised of headquarters and regional
functions.
Section QJ.20, Office of Investigations--Functions
OI conducts criminal, civil, and administrative investigations of
allegations of fraud, waste, abuse, mismanagement, and violations of
standards of conduct within the jurisdiction of OIG. OI establishes
investigative priorities, evaluates the progress of investigations, and
reports findings to the Inspector General. The office develops and
implements investigative techniques, programs, guidelines, and
policies; manages OI's quality assurance/peer review program and
conducts peer reviews of other OIGs. OI also carries out and maintains
an internal quality assurance system. The system includes quality
assessment studies and quality control reviews of OI processes and
products to ensure that policies and procedures are followed
effectively, and are functioning as intended. The office effectuates
mandatory and permissive exclusions from participation in Federal
health care programs under the Social Security Act; decides on all
requests for reinstatement
[[Page 13810]]
from, or waiver of, exclusions; and participates in developing
standards governing the imposition of these exclusion authorities. The
office also oversees OIG's suspension and debarment referral program.
OI implements policies and procedures and plans, develops, implements
and evaluates all levels of training for OI employees. The staff
provides for the personal protection of the Secretary and other
Department officials, as needed, and all emergency operations
preparedness and response. OI coordinates the adoption of advanced
digital forensic acquisition and examination and information security
technologies to assist in the investigation, prevention and detection
of fraud and abuse; maintains an automated data and management
information system used by all OI employees; provides technical
expertise on computer applications for investigations; and coordinates
and approves investigative computer matches with other agencies.
In addition, the office operates a toll-free hotline to permit
individuals to report suspected fraud, waste and abuse within HHS
programs.
Dated: March 9, 2016.
Daniel R. Levinson,
Inspector General.
[FR Doc. 2016-05714 Filed 3-14-16; 8:45 am]
BILLING CODE 4152-01-P